# Monitoring the evolution of vaccine-derived poliovirus in East and Southern African countries, 2010 - 2021

## TL;DR

This study tracks vaccine-derived poliovirus cases in East and Southern Africa from 2010 to 2021, highlighting trends and the impact of surveillance and vaccination efforts.

## Contribution

The study systematically documents VDPV trends in East and Southern Africa over 11 years, linking them to surveillance and vaccination changes.

## Key findings

- 318 VDPVs were reported from 2010 to 2021, with most cases linked to acute flaccid paralysis.
- VDPV2 cases increased after the 2016 switch from tOPV to bOPV.
- The COVID-19 pandemic reduced surveillance and immunization activities, affecting VDPV detection.

## Abstract

the Africa region was certified indigenous wild poliovirus-free in August 2020. Countries in East and Southern Africa have, during acute flaccid paralysis (AFP) and environmental surveillance (ES), detected equally concerning vaccine-derived polioviruses (VDPVs) that have not been systematically documented to guide programming in the sub-region. The study documents trends and salient observations of the VDPVs by country of detection, for 11 years from 2010 to 2021.

we conducted secondary data analysis, a descriptive study design, by deploying field and laboratory of AFP and environmental surveillance databases of the 20 East and Southern African countries from 2010 to 2021.

a total of 318 VDPVs were reported over the study period. The majority were from AFP cases (58.8%) and the rest equally distributed between healthy community children and environmental surveillance sources. More polioviruses were detected after 2016 than during the period before. We observed that more boys were affected by VDPVs compared to girls. Children under 5 years were more affected than other age groups, with a mean age of 3.6 years. Delay of samples in the field seemed to increase the likelihood of not reporting VDPVs and not mounting timely public health detailed investigations and vaccination responses.

the study provides useful evolutional trends of VDPVs for surveillance and vaccination programming. We also noted that the VDPV2s have been increasing after the 2016 tOPV to oral polio vaccine (bOPV) switch. The COVID-19 pandemic emergence in 2020, led to a decline in AFP, ES surveillance, and immunization activities. Our findings point to the need to implement enhanced tailored childhood immunization recovery strategies and to speed up the use of inactivated polio vaccine (IPV) to boost population immunity.